» Articles » PMID: 24459232

Adenine Phosphoribosyltransferase Deficiency As a Rare Cause of Renal Allograft Dysfunction

Overview
Specialty Nephrology
Date 2014 Jan 25
PMID 24459232
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Adenine phosphoribosyltransferase deficiency is a rare autosomal recessive disorder manifesting as urolithiasis or crystalline nephropathy. It leads to the generation of large amounts of poorly soluble 2,8-dihydroxyadenine excreted in urine, yielding kidney injury and in some patients, kidney failure. Early recognition of the disease, institution of xanthine analog therapy to block the formation of 2,8-dihydroxyadenine, high fluid intake, and low purine diet prevent CKD. Because of symptom variability and lack of awareness, however, the diagnosis is sometimes extremely deferred. We describe a patient with adenine phosphoribosyltransferase deficiency who was diagnosed during evaluation of a poorly functioning second kidney allograft. This report highlights the risk of renal allograft loss in patients with undiagnosed adenine phosphoribosyltransferase deficiency and the need for improved early detection of this disease.

Citing Articles

Adenine phosphoribosyltransferase (APRT) deficiency: an increasingly recognized disease.

Leow E, Ganesan I, Chong S, Yap C, Chao S, Wang F Int Urol Nephrol. 2025; .

PMID: 39982660 DOI: 10.1007/s11255-025-04420-6.


Untargeted metabolomics reveals gender- and age- independent metabolic changes of type 1 diabetes in Chinese children.

Zhang J, Wu W, Huang K, Dong G, Chen X, Xu C Front Endocrinol (Lausanne). 2023; 13:1037289.

PMID: 36619558 PMC: 9813493. DOI: 10.3389/fendo.2022.1037289.


Adenine phosphoribosyl transferase deficiency leads to renal allograft dysfunction in kidney transplant recipients: a systematic review.

Rashid I, Verma A, Tiwari P, DCruz S J Bras Nefrol. 2022; 44(3):403-416.

PMID: 35635787 PMC: 9518620. DOI: 10.1590/2175-8239-JBN-2021-0283en.


Recurrence of 2,8-dihydroxyadenine Crystalline Nephropathy in a Kidney Transplant Recipient: A Case Report and Literature Review.

Cheng Y, Guo L, Wang M, Chen J, Wang R Intern Med. 2021; 60(16):2651-2657.

PMID: 33678741 PMC: 8429296. DOI: 10.2169/internalmedicine.6640-20.


Kidney Transplant Outcomes in Patients With Adenine Phosphoribosyltransferase Deficiency.

Runolfsdottir H, Palsson R, Agustsdottir I, Indridason O, Li J, Dao M Transplantation. 2019; 104(10):2120-2128.

PMID: 31880754 PMC: 7316615. DOI: 10.1097/TP.0000000000003088.


References
1.
Harambat J, Bollee G, Daudon M, Ceballos-Picot I, Bensman A . Adenine phosphoribosyltransferase deficiency in children. Pediatr Nephrol. 2012; 27(4):571-9. DOI: 10.1007/s00467-011-2037-0. View

2.
Sahota A, Chen J, Boyadjiev S, GAULT M, Tischfield J . Missense mutation in the adenine phosphoribosyltransferase gene causing 2,8-dihydroxyadenine urolithiasis. Hum Mol Genet. 1994; 3(5):817-8. DOI: 10.1093/hmg/3.5.817. View

3.
Edvardsson V, Palsson R, Olafsson I, Hjaltadottir G, Laxdal T . Clinical features and genotype of adenine phosphoribosyltransferase deficiency in iceland. Am J Kidney Dis. 2001; 38(3):473-80. DOI: 10.1053/ajkd.2001.26826. View

4.
Kouri T, Gant V, Fogazzi G, Hofmann W, Hallander H, Guder W . Towards European urinalysis guidelines. Introduction of a project under European Confederation of Laboratory Medicine. Clin Chim Acta. 2000; 297(1-2):305-11. DOI: 10.1016/s0009-8981(00)00256-4. View

5.
Benedetto B, Madden R, Kurbanov A, Braden G, Freeman J, Lipkowitz G . Adenine phosphoribosyltransferase deficiency and renal allograft dysfunction. Am J Kidney Dis. 2001; 37(5):E37. DOI: 10.1016/s0272-6386(05)90001-2. View